期刊文献+

系统性红斑狼疮患者治疗前后血清TNF-α、IL-6和sIL-2R水平变化及临床意义 被引量:7

在线阅读 下载PDF
导出
摘要 目的:探讨系统性红斑狼疮( SLE)患者治疗前后肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和可溶性白细胞介素-2受体(sIL-2R)的水平变化及对免疫功能的影响。方法:采用固相酶标记化学发光免疫分析技术检测40例SLE患者激素治疗前后血清TNF-α、IL-6和sIL-2R水平,应用免疫速率散射比浊法测定免疫球蛋白G(IgG)和补体3(C3)水平。以30例体检正常者作对照。结果:40例SLE患者治疗前活动期血清IgG、TNF-α、IL-6和sIL-2R水平明显高于正常对照组,而C3水平明显低于正常对照组,均P<0.01。经激素治疗后(稳定期),SLE患者血清IgG、TNF-α、IL-6和sIL-2R水平显著下降,C3显著升高,均P<0.01,但IgG、C3、TNF-α和IL-6水平仍与正常对照组有显著统计学差异(P<0.01)。结论:SLE患者TNF-α、IL-6和sIL-2R表达增加,提示SLE的发病过程涉及免疫紊乱和细胞因子失平衡。
出处 《微循环学杂志》 2010年第3期50-52,共3页 Chinese Journal of Microcirculation
  • 相关文献

参考文献6

二级参考文献16

  • 1郭小兵,王鹏,刘红春.SLE患者血清免疫球蛋白及补体C_3含量检测[J].河南职工医学院学报,2007,19(5):481-482. 被引量:7
  • 2Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator[J]. Science, 1999, 285(5425): 260-263.
  • 3Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease[J]. Nature, 2000, 404(6781): 995-999.
  • 4Stohl W. Systemic lupus erythematosus: a blissless disease of too much BLyS (Blymphocyte stimulator) protein [J]. Curr Opin Rheumatol, 2002, 14(5): 522-528.
  • 5Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome[J]. Ann Rheum Dis, 2003, 62(2): 168-171.
  • 6Krumbholz M, Theil D, Derfuss T, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma [J]. J Exp Med, 2005,201(2): 195-200.
  • 7Novak A J, Darce JR, Arendt Bk, et al. Expression of BCMA,TAC1, and BAFF-R in multiple myeloma: a mechanism for growth and survival[J]. Blood, 2004, 103(2): 689-694.
  • 8Rodriguez B, Valdez H, Freimuth W, et al. Plasma levels of B-lymphocyte stimulator increase with HIV disease progression [J].AIDS, 2003, 17(13): 1983-1985.
  • 9Novak AJ, Grote DM, Stenson M, et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome [J]. Blood, 2004, 104(8):2247-2253.
  • 10Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE[J]. Arthritis Rheum, 1992,35(6): 630-640.

共引文献30

同被引文献90

引证文献7

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部